What intravenous antipsychotics and dosing protocols are recommended for an adult with acute severe agitation or psychosis who cannot take oral medication?

IV Antipsychotics for Acute Severe Agitation

For adults requiring IV medication for acute severe agitation or psychosis, use IV droperidol 5 mg combined with IV midazolam 2.5-5 mg as first-line therapy, as this combination provides the fastest sedation (median 4-6 minutes faster than alternatives) with comparable safety. 1, 2, 3

Primary Recommendation: IV Droperidol-Midazolam Combination

The evidence strongly supports IV droperidol 5 mg plus IV midazolam 5 mg as the most effective regimen 3. This combination:

• Achieves adequate sedation in 75% of patients at 10 minutes (25% more than monotherapy alternatives)
• Reduces time to sedation by 6 minutes compared to droperidol or olanzapine alone
• Requires fewer rescue doses
• Shows no difference in adverse events compared to monotherapy 3

Dosing protocol:

• Initial: Droperidol 5 mg IV + Midazolam 5 mg IV bolus
• If inadequate at 10 minutes: Additional midazolam 5 mg IV (up to 2 additional doses)
• Reassess every 10 minutes

Alternative IV Antipsychotic Options

If Droperidol Unavailable or Contraindicated:

IV Olanzapine 5-10 mg is the next best option 2, 3:

• When combined with midazolam: reduces time to sedation by 5 minutes versus midazolam alone
• Better tolerated than haloperidol with fewer extrapyramidal symptoms
• Can give up to 10 mg IV initially, with 5 mg additional doses if needed

IV Haloperidol 5 mg remains an evidence-based option 1:

• Extensive safety data across 20+ double-blind studies
• Standard dose: 5 mg IV, can repeat every 30-60 minutes
• Critical caveat: Higher risk of extrapyramidal symptoms and dystonia compared to atypicals
• Consider combining with lorazepam 2 mg IV for faster sedation (Level C recommendation) 1

Important Safety Considerations

Droperidol Black Box Warning Context

Despite the FDA black box warning for QTc prolongation, large safety studies demonstrate excellent safety 1:

• Review of 2,468 ED patients (1,357 for agitation): only 6 adverse events, none were dysrhythmias
• No documented dysrhythmias in estimated 12,000 patients treated for agitation
• QTc prolongation occurs but rarely exceeds 500 ms clinically 1

Practical approach: Use droperidol unless patient has known prolonged QTc >500 ms, recent cardiac arrest, or is on multiple QT-prolonging medications.

Age-Specific Warning for Older Adults (≥65 years)

Avoid IV midazolam in older adults - it poses elevated risk of serious adverse events (16.8% rate) without efficacy gains 4. For geriatric patients:

• Prefer oral medications when possible (quetiapine has best safety profile)
• Use lowest effective doses
• IV/IM routes increase adverse events versus oral administration 4

Clinical Decision Algorithm

Step 1: Assess for reversible medical causes (hypoglycemia, hypoxia, anticholinergic toxicity, sympathomimetic intoxication) - antipsychotics can worsen anticholinergic-mediated agitation 1

Step 2: Attempt verbal de-escalation first 1

Step 3: If IV medication required:

• Age <65 years: Droperidol 5 mg + Midazolam 5 mg IV
• Age ≥65 years: Consider oral quetiapine or lowest-dose IV olanzapine 5 mg (avoid midazolam) 4
• Known psychotic disorder: Any antipsychotic appropriate; atypicals preferred for lower EPS risk 1
• Undifferentiated agitation: Droperidol-midazolam or benzodiazepine monotherapy acceptable 1

Step 4: Reassess at 10 minutes:

• If inadequate: Give additional midazolam 5 mg IV (or additional 5 mg of chosen antipsychotic)
• Maximum 3 total doses before considering alternative agent

Key Pitfalls to Avoid

1. Don't use IV haloperidol as monotherapy when combination therapy available - combination with benzodiazepine produces faster sedation 1

2. Don't assume all antipsychotics are equivalent - droperidol provides significantly faster sedation than haloperidol when rapid control needed 1

3. Don't forget anticholinergic toxicity - antipsychotics and EPS treatments can worsen agitation from anticholinergic or sympathomimetic poisoning 1

4. Don't use standard adult doses in elderly - serious adverse events occur in 16.8% of older adults receiving these medications 4

5. Don't overlook ziprasidone IM 20 mg - while not truly IV, it shows excellent efficacy with notably absent movement disorders and may be preferable when IM access acceptable 1

The evidence hierarchy clearly favors combination therapy over monotherapy, with droperidol-midazolam demonstrating superior time-to-sedation and efficacy outcomes in the highest quality randomized controlled trials 3.